NumerixS Investment Technologies’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-8,202
Closed -$359K 1273
2020
Q1
$359K Sell
8,202
-1,600
-16% -$76.6K 0.18% 118
2019
Q4
$492K Buy
9,802
+7,902
+416% +$370K 0.1% 240
2019
Q3
$88K Sell
1,900
-9,900
-84% -$427K 0.02% 587
2019
Q2
$511K Sell
11,800
-6,000
-34% -$255K 0.15% 173
2019
Q1
$788K Buy
17,800
+12,216
+219% +$523K 0.11% 237
2018
Q4
$240K Buy
+5,584
New +$246K 0.08% 290
2017
Q4
Sell
-7,200
Closed -$358K 1341
2017
Q3
$358K Sell
7,200
-1,200
-14% -$58.1K 0.08% 323
2017
Q2
$402K Buy
8,400
+3,000
+56% +$143K 0.06% 404
2017
Q1
$244K Buy
+5,400
New +$229K 0.03% 657
2016
Q4
Sell
-7,000
Closed -$267K 1317
2016
Q3
$267K Buy
+7,000
New +$281K 0.03% 594
2016
Q2
Sell
-10,000
Closed -$402K 1232
2016
Q1
$402K Buy
+10,000
New +$402K 0.05% 545
2015
Q3
Sell
-6,989
Closed -$346K 764
2015
Q2
$346K Buy
+6,989
New +$354K 0.05% 463
2015
Q1
Sell
-5,400
Closed -$246K 676
2014
Q4
$246K Buy
+5,400
New +$262K 0.08% 364

Other funds holding SNY

NumerixS Investment Technologies's SNY Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Sanofi (SNY) in Q2 2020, closing a stake of 8,202 shares — an estimated $359K sold.

NumerixS Investment Technologies first reported a position in SNY in Q4 2014 and held it in 13 quarters. The position peaked at $788K in Q1 2019. 583 funds tracked by Wall St. Rank hold SNY as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Sanofi position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 8,202 Sanofi shares in Q2 2020, an estimated $359K.
  • NumerixS Investment Technologies first reported a position in Sanofi in Q4 2014 and held it in 13 quarters.
  • NumerixS Investment Technologies's Sanofi position peaked at $788K in Q1 2019.
  • 583 funds tracked by Wall St. Rank held Sanofi as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.